Małgorzata Żuk
Biographic Data
| ID | 8262753 |
|---|---|
| NAME | Małgorzata Żuk |
| GIVEN NAMES | Małgorzata |
| FAMILY NAME | Żuk |
| SIGNATURE | ZUK M |
| AFFILIATIONS | Children's Memorial Health Institute |
| ORCID | 0000-0002-2203-9382 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
Children with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension Treated with Pulmonary Vasodilators—The Pediatric Cardiologist Point of View
Pulmonary hypertension in children with bronchopulmonary dysplasia (BPD-PH) significantly worsens the prognosis. Pulmonary vasodilators are often used in BPD-PH but the short-term outcome of treatment is not well described. The aim of this study was to evaluate BPD-PH children diagnosed beyond 36 weeks postmenstrual age treated with pulmonary vasodilators (sildenafil, bosentan, or both) and to assess the short and long-term effect of oral pulmona…
No prominent works on this page.
Children with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension Treated with Pulmonary Vasodilators—The Pediatric Cardiologist Point of View
Pulmonary hypertension in children with bronchopulmonary dysplasia (BPD-PH) significantly worsens the prognosis. Pulmonary vasodilators are often used in BPD-PH but the short-term outcome of treatment is not well described. The aim of this study was to evaluate BPD-PH children diagnosed beyond 36 weeks postmenstrual age treated with pulmonary vasodilators (sildenafil, bosentan, or both) and to assess the short and long-term effect of oral pulmona…
Bosentan (1 work) · Bronchopulmonary dysplasia (1 work) · Cardiology (1 work) · Congenital Diaphragmatic Hernia Studies (1 work) · Discontinuation (1 work) · Internal Medicine (1 work) · Medicine (1 work) · Neonatal Respiratory Health Research (1 work) · Pulmonary artery (1 work) · Pulmonary hypertension (1 work)